Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China

Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China

Abstract Background Limited data exist regarding the efficacy and safety of vedolizumab (VDZ) in China’s elderly adult population with ulcerative colitis (UC) in China. In this investigation, a comparative analysis of its efficacy and safety was performed between elderly and younger adult UC cohorts...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Zhang, Xue-Li Ding, Yong-Hong Xu, Jun Wu, Yue-Yuan Wang, Shu-Xian Liu, Jing Yan, Hua Liu, Zi-Bin Tian, Ai-Ling Liu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Gastroenterology
Subjects:
Ulcerative colitis
Vedolizumab
Elderly
Efficacy
Safety
Online Access:https://doi.org/10.1186/s12876-025-04125-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-04125-1

Similar Items